Clorox Co (NYSE:CLX) SVP Michael R. Costello Sells 3,225 Shares

Clorox Co (NYSE:CLX) SVP Michael R. Costello sold 3,225 shares of the business’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $161.34, for a total transaction of $520,321.50. Following the transaction, the senior vice president now owns 29,669 shares in the company, valued at approximately $4,786,796.46. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Shares of NYSE:CLX traded down $1.42 on Friday, hitting $157.73. 15,531 shares of the company were exchanged, compared to its average volume of 1,069,086. The company’s 50 day moving average price is $159.50 and its two-hundred day moving average price is $155.85. Clorox Co has a one year low of $141.53 and a one year high of $167.70. The company has a debt-to-equity ratio of 4.09, a quick ratio of 0.55 and a current ratio of 0.91. The firm has a market capitalization of $20.01 billion, a price-to-earnings ratio of 24.93, a PEG ratio of 5.00 and a beta of 0.37.

Clorox (NYSE:CLX) last issued its earnings results on Thursday, August 1st. The company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.04. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The business had revenue of $1.63 billion for the quarter, compared to analyst estimates of $1.69 billion. During the same period in the previous year, the business earned $1.66 EPS. The firm’s revenue was down 3.8% on a year-over-year basis. Research analysts predict that Clorox Co will post 6.4 earnings per share for the current year.



CLX has been the topic of several research reports. BMO Capital Markets set a $168.00 price objective on shares of Clorox and gave the stock a “buy” rating in a report on Thursday, May 2nd. ValuEngine downgraded shares of Clorox from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Morgan Stanley boosted their price objective on shares of Clorox from $141.00 to $144.00 and gave the stock an “underweight” rating in a report on Friday, August 2nd. UBS Group boosted their price objective on shares of Clorox from $110.00 to $128.00 and gave the stock a “sell” rating in a report on Friday, August 2nd. Finally, Citigroup set a $156.00 price objective on shares of Clorox and gave the stock a “hold” rating in a report on Thursday, May 23rd. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $154.07.

Several institutional investors have recently modified their holdings of CLX. CWM LLC boosted its position in Clorox by 75.6% in the second quarter. CWM LLC now owns 92,127 shares of the company’s stock valued at $14,106,000 after buying an additional 39,668 shares in the last quarter. Mn Services Vermogensbeheer B.V. boosted its position in Clorox by 0.6% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 70,968 shares of the company’s stock valued at $11,388,000 after buying an additional 400 shares in the last quarter. SlateStone Wealth LLC boosted its position in Clorox by 13.6% in the first quarter. SlateStone Wealth LLC now owns 5,043 shares of the company’s stock valued at $809,000 after buying an additional 605 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC boosted its position in Clorox by 1.1% in the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 35,017 shares of the company’s stock valued at $5,619,000 after buying an additional 384 shares in the last quarter. Finally, Sadoff Investment Management LLC boosted its position in Clorox by 0.7% in the first quarter. Sadoff Investment Management LLC now owns 127,494 shares of the company’s stock valued at $20,458,000 after buying an additional 945 shares in the last quarter. Institutional investors and hedge funds own 75.88% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: Special Dividends

Insider Buying and Selling by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.